Post-trial obligations - DOI: 10.3395/reciis.v2.Sup1.210en
In its essence, post-trial obligations describe a duty by research sponsors to provide a successfully tested drug to research participants who took part in the relevant clinical trials after the trial has been concluded. In some instances, this duty is extended beyond the research participants. This...
Saved in:
Main Author: | Doris Schroeder (Author) |
---|---|
Format: | Book |
Published: |
Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Icict) da Fundação Oswaldo Cruz (Fiocruz),
2008-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Payment for research participants - DOI: 10.3395/reciis.v2.Sup1.209en
by: Leonardo D. de Castro
Published: (2008) -
Special populations: vulnerability and protection - DOI: 10.3395/reciis.v2.Sup1.207en
by: Wendy Rogers, et al.
Published: (2008) -
Research Ethics: advances and challenges - DOI: 10.3395/reciis.v2.Sup1.212en
by: Dirce Guilhem
Published: (2008) -
Research Ethics - Global Topics - DOI: 10.3395/reciis.v2.Sup1.201en
by: Débora Diniz, et al.
Published: (2008) -
Editorial - DOI: 10.3395/reciis.v3i4.329pt
by: Maria Cristina Soares Guimarães, et al.
Published: (2009)